These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30677243)

  • 1. Diamondoid Amino Acid-Based Peptide Kinase A Inhibitor Analogues.
    Müller J; Kirschner RA; Berndt JP; Wulsdorf T; Metz A; Hrdina R; Schreiner PR; Geyer A; Klebe G
    ChemMedChem; 2019 Mar; 14(6):663-672. PubMed ID: 30677243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of synthetic peptide inhibitor and substrate of cAMP-dependent protein kinase. A study by 2D H NMR and molecular dynamics.
    Padilla A; Hauer JA; Tsigelny I; Parello J; Taylor SS
    J Pept Res; 1997 Mar; 49(3):210-20. PubMed ID: 9151254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
    Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
    Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A.
    Manschwetus JT; Bendzunas GN; Limaye AJ; Knape MJ; Herberg FW; Kennedy EJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31009996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the hot spot residues for pyridine derivative inhibitor CCT251455 and ATP substrate binding on monopolar spindle 1 (MPS1) kinase by molecular dynamic simulation.
    Chen K; Duan W; Han Q; Sun X; Li W; Hu S; Wan J; Wu J; Ge Y; Liu D
    J Biomol Struct Dyn; 2019 Feb; 37(3):611-622. PubMed ID: 29380674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid derived quinazolines as Rock/PKA inhibitors.
    Chowdhury S; Chen YT; Fang X; Grant W; Pocas J; Cameron MD; Ruiz C; Lin L; Park H; Schröter T; Bannister TD; Lograsso PV; Feng Y
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1592-9. PubMed ID: 23416002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two simultaneous aza-β3-amino acid substitutions on recognition of peptide substrates by cAMP dependent protein kinase catalytic subunit.
    Kisseljova K; Kuznetsov A; Baudy-Floc'h M; Järv J
    Bioorg Chem; 2011 Aug; 39(4):133-7. PubMed ID: 21683975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis of furanoid epsilon-sugar amino acid containing cyclic peptides by NMR spectroscopy, molecular dynamics simulation, and X-ray crystallography: evidence for a novel turn structure.
    van Well RM; Marinelli L; Altona C; Erkelens K; Siegal G; van Raaij M; Llamas-Saiz AL; Kessler H; Novellino E; Lavecchia A; van Boom JH; Overhand M
    J Am Chem Soc; 2003 Sep; 125(36):10822-9. PubMed ID: 12952461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool.
    Åberg E; Lund B; Pflug A; Gani OA; Rothweiler U; de Oliveira TM; Engh RA
    Biol Chem; 2012 Oct; 393(10):1121-9. PubMed ID: 23092797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
    Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
    Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into AGC kinase inhibition.
    Breitenlechner C; Gassel M; Engh R; Bossemeyer D
    Oncol Res; 2004; 14(6):267-78. PubMed ID: 15206489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.
    Hundsrucker C; Krause G; Beyermann M; Prinz A; Zimmermann B; Diekmann O; Lorenz D; Stefan E; Nedvetsky P; Dathe M; Christian F; McSorley T; Krause E; McConnachie G; Herberg FW; Scott JD; Rosenthal W; Klussmann E
    Biochem J; 2006 Jun; 396(2):297-306. PubMed ID: 16483255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
    Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
    Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.
    Glass DB; Trewhella J; Mitchell RD; Walsh DA
    Protein Sci; 1995 Mar; 4(3):405-15. PubMed ID: 7795524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
    Xu R; Banka A; Blake JF; Mitchell IS; Wallace EM; Bencsik JR; Kallan NC; Spencer KL; Gloor SL; Martinson M; Risom T; Gross SD; Morales TH; Wu WI; Vigers GP; Brandhuber BJ; Skelton NJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2335-40. PubMed ID: 21420856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for regulatory subunit diversity in cAMP-dependent protein kinase: crystal structure of the type II beta regulatory subunit.
    Diller TC; Madhusudan ; Xuong NH; Taylor SS
    Structure; 2001 Jan; 9(1):73-82. PubMed ID: 11342137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
    Panigrahi SK
    Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.